reglab/housing_qa huggingface dataset:
CA Health & Safety Code § 120905 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 4 - Acquired Immune Deficiency Syndrome (AIDS) Early Intervention Projects|Section 120905.

120905.  (a)  The director shall commence awarding contracts to projects on or before July 1, 1990. In awarding contracts to early intervention projects, the director may select projects from each of the following models: (1)  A privately operated profit or nonprofit clinic that is not licensed as part of a health facility and that provides all of the services specified in subdivision (b) of Section 120900. (2)  A publicly operated clinic that is not licensed as part of a health facility and that provides all of the services specified in subdivision (b) of Section 120900. (3)  A combination of independent privately operated clinics, publicly operated clinics, and other health care providers that in total provide all of the services specified in subdivision (b) of Section 120900. (4)  Any other model that the director considers worthy of receiving funds. (b)  An applicant for a contract to operate an early intervention project that is not a part of a county health department shall submit its application to the county health department for review and comment. The county health department shall provide comment on the application to the department within a time period to be specified by the department. The failure by a county health department to comment on an application submitted to it within the time period specified by the department shall not jeopardize the application, and the department in a case of this nature may process and award a contract in the absence of comment by the county health department. (c)  An applicant for a contract to operate an early intervention project shall indicate in its application how it intends to coordinate with county health department programs, community-based organizations that provide HIV-related services, and other public and private entities that may provide services to a person who is infected with HIV. (Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 120910 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 4 - Acquired Immune Deficiency Syndrome (AIDS) Early Intervention Projects|Section 120910.

120910.  (a)  The department shall collect data from the early intervention projects, assess the effectiveness of the different models of early intervention projects.(b)  The department shall continuously collect data from each early intervention project. The data collected may include, but not be limited to, the following:(1)  The total number of clients served.(2)  The number of clients utilizing each service provided by the project.(3)  Demographics on clients in the aggregate.(4)  The source of funding for each type of service provided.(5)  The cost of each type of service provided.(6)  Medical treatment modalities utilized in the aggregate.(7)  Changes in the clinical status of clients in the aggregate.(8)  Changes in behaviors that present risks of transmitting HIV infection of the clients in the aggregate.(9)  The psychosocial changes of clients in the aggregate.(10)  Referrals made by the project.(11)  Perceived unmet needs of the clients served by the project.(c)  The department shall develop and distribute to each early intervention project forms for data collection that are designed to elicit information necessary for the department to comply with the requirements of subdivision (b). The data may be used by the department to comply with the requirements of subdivision (a).(Amended by Stats. 2012, Ch. 728, Sec. 105. (SB 71) Effective January 1, 2013.)
CA Health & Safety Code § 120920 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 4 - Acquired Immune Deficiency Syndrome (AIDS) Early Intervention Projects|Section 120920.

120920.  The Legislature hereby finds and declares that people with HIV infection may not avail themselves of early intervention services unless they are aware of the availability of the services and the efficacy of early intervention in prolonging life. This awareness by HIV-infected persons is critical to maximizing the benefits of early intervention. Therefore, it is the intent of the Legislature that the department includes early intervention education as a component of information and education grants in the first grant cycle following enactment of Sections 120900 to 120920, inclusive.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 120925 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 5 - Provision of Azidothymidine|Section 120925.

120925.  The Legislature hereby finds and declares all of the following:(a)  The drug azidothymidine (AZT) improves and prolongs the quality of life for those suffering from acquired immune deficiency syndrome (AIDS) or AIDS-related conditions, is believed to reduce the infectiousness of a person infected with human immunodeficiency virus (HIV), and is the only drug approved by the federal Food and Drug Administration for treatment of AIDS and AIDS-related conditions. (b)  Hundreds of Californians infected with HIV are receiving AZT due to a subsidy for AZT made available by the federal government for low-income people. (c)  The department estimates that it will have sufficient federal funds to maintain those enrolling in the program prior to October 1, 1988, through April 1989, if it terminates new enrollees beginning October 1, 1988. (d)  The department intends to direct counties to cease accepting new enrollees for the subsidy program beginning October 1, 1988, because of the exhaustion of these federal funds. (e)  The federal government has an obligation to continue to support the subsidy program that it has initiated because of the horrendous moral consequences of terminating the access of low-income infected people to the drug. (f)  The funding cycle for federal programs precludes appropriating additional funds to maintain this program until June of 1989. (Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 120930 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 5 - Provision of Azidothymidine|Section 120930.

120930.  It is the intent of the Legislature that the State of California continue to provide temporary funding for the program to ensure that those whose health depends on obtaining access to AZT and who are unable to afford it can receive the drug during this interim period.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 120935 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 5 - Provision of Azidothymidine|Section 120935.

120935.  The department shall continue through June 1989, the AZT subsidy program established in 1987 with federal funds. The department shall maintain the eligibility standards used for the program as of August 1988. The department shall allocate to local health jurisdictions the funds appropriated to support the subsidy program. The department may reallocate funds among these local health jurisdictions as needed to ensure that persons requiring the subsidy receive it through June 1989.(Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 120950 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 6 - Human Immunodeficiency Virus (HIV) Treatment|Section 120950.

120950.  The Legislature hereby finds and declares all of the following:(a)  State-of-art knowledge regarding treatment of people infected with the human immunodeficiency virus (HIV) indicates that active HIV infection (AIDS) can be a manageable, though chronic, condition with the use of drugs such as zidovudine (AZT), aerosolized pentamidine, and ganciclovir. AIDS experts across the nation agree that early intervention with these drugs can prolong life, minimize the related occurrences of more serious illnesses, reduce more costly treatments, and maximize the HIV-infected person’s vitality and productivity. (b)  For reasons of compassion and cost effectiveness, the State of California has a compelling interest in ensuring that its citizens infected with the HIV virus have access to these drugs. (c)  The department subsidizes the cost of these drugs for persons who do not have private health coverage, are not eligible for Medi-Cal, or cannot afford to purchase the drug privately. The subsidy program is funded through state and federal sources. (d)  Congress is expected to place limitations on the federal subsidy program that will jeopardize access to these life-prolonging drugs for people whose income is higher than federal income eligibility cap but lower than the state’s income eligibility cap. (e)  It is critical that suffering persons with limited income have access to life-prolonging drugs. It is also critical that persons currently eligible for the subsidy program remain eligible regardless of changes that may result from the congressional action and the enactment of this chapter. However, it is appropriate that people who can afford to pay a portion of the cost of treatment be obligated to share the cost of these drugs. (Added by Stats. 1995, Ch. 415, Sec. 7. Effective January 1, 1996.)
CA Health & Safety Code § 120956 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 6 - Human Immunodeficiency Virus (HIV) Treatment|Section 120956.

120956.  (a) The AIDS Drug Assistance Program Rebate Fund is hereby created as a special fund in the State Treasury.(b) All rebates collected from drug manufacturers on drugs purchased through the AIDS Drugs Assistance Program (ADAP) implemented pursuant to this chapter and, notwithstanding Section 16305.7 of the Government Code, interest earned on these moneys shall be deposited in the fund exclusively to cover costs related to the purchase of drugs and services provided through ADAP and the HIV prevention programs as described in Sections 120972 and 120972.1.(c) Notwithstanding Section 13340 of the Government Code, moneys in the fund are continuously appropriated without regard to fiscal year to State Department of Public Health and available for expenditure for those purposes specified under this section.(Amended by Stats. 2021, Ch. 143, Sec. 23. (AB 133) Effective July 27, 2021.)
CA Health & Safety Code § 120960 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 6 - Human Immunodeficiency Virus (HIV) Treatment|Section 120960.

120960.  (a) The department shall establish uniform standards of financial eligibility for the drugs under the program established under this chapter.(b) Nothing in the financial eligibility standards shall prohibit drugs to an otherwise eligible person whose modified adjusted gross income does not exceed 500 percent of the federal poverty level per year based on family size and household income. However, the director may authorize drugs for persons with incomes higher than 500 percent of the federal poverty level per year based on family size and household income if the estimated cost of those drugs in one year is expected to exceed 20 percent of the person’s modified adjusted gross income.(c) A county public health department administering this program pursuant to an agreement with the director pursuant to subdivision (b) of Section 120955 shall use no more than 5 percent of total payments it collects pursuant to this section to cover any administrative costs related to eligibility determinations, reporting requirements, and the collection of payments.(d) A county public health department administering this program pursuant to subdivision (b) of Section 120955 shall provide all drugs added to the program pursuant to subdivision (a) of Section 120955 within 60 days of the action of the director.(e) For purposes of this section, the following terms shall have the following meanings:(1) “Family size” has the meaning given to that term in Section 36B(d)(1) of the Internal Revenue Code of 1986, and shall include same or opposite sex married couples, registered domestic partners, and any tax dependents, as defined by Section 152 of the Internal Revenue Code of 1986, of either spouse or registered domestic partner.(2) “Federal poverty level” refers to the poverty guidelines updated periodically in the Federal Register by the United States Department of Health and Human Services under the authority of Section 9902(2) of Title 42 of the United States Code.(3) “Household income” means the sum of the applicant’s or recipient’s modified adjusted gross income, plus the modified adjusted gross income of the applicant’s or recipient’s spouse or registered domestic partner, and the modified adjusted gross incomes of all other individuals for whom the applicant or recipient, or the applicant’s or recipient’s spouse or registered domestic partner, is allowed a federal income tax deduction for the taxable year.(4) “Internal Revenue Code of 1986” means Title 26 of the United States Code, including all amendments enacted to that code.(5) “Modified adjusted gross income” has the meaning given to that term in Section 36B(d)(2)(B) of the Internal Revenue Code of 1986.(Amended by Stats. 2016, Ch. 30, Sec. 5. (SB 833) Effective June 27, 2016.)
CA Health & Safety Code § 120966 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 6 - Human Immunodeficiency Virus (HIV) Treatment|Section 120966.

120966.  (a)  (1)  The program established under this chapter shall make available to any eligible person under this chapter any antiviral drug that is approved by the federal Food and Drug Administration for treatment of human immunodeficiency virus (HIV) or acquired immune deficiency syndrome (AIDS), prescribed by the beneficiary’s medical care provider, and approved by the AIDS Drug Assistance Program Medical Advisory Committee of the Office of AIDS if determined by the State Department of Health Services that the new antiviral drug would be used as an additional treatment option, and anticipated client utilization represents no significant additional cost to the program and does not require the removal of another antiviral drug from the formulary. (2)  Any federal Food and Drug Administration-approved antiviral drug that is determined by the State Department of Health Services to represent a significant additional cost to the program shall be made available if, after an analysis is conducted by the department, it determines that the program has an adequate budget to fund the addition of the new drug. (3)  The department shall use all reasonable means to ensure that the determination required in paragraph (1) or the analysis required by paragraph (2) are performed as promptly as possible. (b)  Notwithstanding any other provision of law, any antiviral drug that is approved pursuant to paragraph (1) of subdivision (a) for addition to the formulary of drugs program established by this chapter shall be available to patients covered by the program established by this chapter within 30 days of the Office of AIDS being notified by the drug’s manufacturer of the FDA approval. (Added by Stats. 1999, Ch. 497, Sec. 1. Effective January 1, 2000.)
CA Health & Safety Code § 120968 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 6 - Human Immunodeficiency Virus (HIV) Treatment|Section 120968.

120968.  The Office of AIDS shall report to the Legislature no later than October 1, 2000, the status of consumer protections for the AIDS drug program established pursuant to this chapter, including a report on the contractor’s performance in each of the following areas:(a)  Filling of patient prescriptions within 24 hours of submission, and shipping of mail order prescriptions within 48 hours. (b)  Subcontracting with any willing provider, including a report on any denials of contracts with providers and the reason for denial. (c)  Provision of information regarding program policies, procedures, enrollment procedures, eligibility guidelines, and lists of drugs covered in appropriate literacy levels in English, Spanish, Mandarin/Cantonese, Tagalog, and in other languages as determined by the department. (d)  Development of a timely and accessible grievance procedure for clients, promotion of that procedure among clients, and utilization. (Added by Stats. 1999, Ch. 497, Sec. 2. Effective January 1, 2000.)
CA Health & Safety Code § 120971 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 6 - Human Immunodeficiency Virus (HIV) Treatment|Section 120971.

120971.  (a) In the event state expenditures for the AIDS Drug Assistance Program (ADAP) are identified by California to be used as a certified public expenditure for the purpose of obtaining federal financial participation under the Medi-Cal program for any purposes, including federal demonstration waivers, the State Department of Health Care Services and the State Department of Public Health shall ensure the integrity of the ADAP in meeting its maintenance-of-effort requirements to receive federal funds and to obtain all ADAP drug rebates to support the ADAP.(b) The State Department of Health Care Services and the State Department of Public Health shall keep the appropriate policy and fiscal committees of the Legislature informed of any potential concerns that may arise in the event that state expenditures for the ADAP are used as a certified public expenditure as described in subdivision (a).(Added by Stats. 2010, Ch. 717, Sec. 15. (SB 853) Effective October 19, 2010.)
CA Health & Safety Code § 120973 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 6.2 - HIV Care Program|Section 120973.

120973.  The following definitions apply for purposes of this chapter:(a) “ADAP” means the AIDS Drug Assistance Program.(b) “HIV Care Program” means the CARE Services Program referenced in subparagraph (C) of paragraph (1) of subdivision (a) of Section 131051. Any reference to the CARE Services Program is deemed a reference to the HIV Care Program.(c) The HIV Care Program provides primary medical care and support services pursuant to the federal Ryan White CARE Act (42 U.S.C. Sec. 300ff), and is administered by the Office of AIDS in the State Department of Public Health in accordance with Sections 131019 and 131051.(Added by Stats. 2019, Ch. 38, Sec. 24. (SB 78) Effective June 27, 2019. Section operative April 1, 2020, pursuant to Section 120974.)
CA Health & Safety Code § 120973.5 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 6.2 - HIV Care Program|Section 120973.5.

120973.5  The State Department of Public Health shall apply the same financial eligibility requirements for the purposes of administering the HIV Care Program as those set forth for the ADAP in Section 120960.(Added by Stats. 2019, Ch. 38, Sec. 24. (SB 78) Effective June 27, 2019. Section operative April 1, 2020, pursuant to Section 120974.)
CA Health & Safety Code § 120974 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 6.2 - HIV Care Program|Section 120974.

120974.  This chapter shall become operative on April 1, 2020.(Added by Stats. 2019, Ch. 38, Sec. 24. (SB 78) Effective June 27, 2019.)
CA Health & Safety Code § 120975 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 7 - Mandated Blood Testing and Confidentiality to Protect Public Health|Section 120975.

120975.  To protect the privacy of individuals who are the subject of testing for human immunodeficiency virus (HIV), the following shall apply:Except as provided in Section 1603.1, 1603.3, or 121022, no person shall be compelled in any state, county, city, or other local civil, criminal, administrative, legislative, or other proceedings to identify or provide identifying characteristics that would identify any individual who is the subject of an HIV test, as defined in subdivision (c) of Section 120775.(Amended by Stats. 2013, Ch. 445, Sec. 1. (SB 249) Effective January 1, 2014.)
CA Health & Safety Code § 120985 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 105 - COMMUNICABLE DISEASE PREVENTION AND CONTROL|PART 4 - HUMAN IMMUNODEFICIENCY VIRUS (HIV)|CHAPTER 7 - Mandated Blood Testing and Confidentiality to Protect Public Health|Section 120985.

120985.  (a)  Notwithstanding Section 120980, the results of an HIV test that identifies or provides identifying characteristics of the person to whom the test results apply may be recorded by the physician who ordered the test in the test subject’s medical record or otherwise disclosed without written authorization of the subject of the test, or the subject’s representative as set forth in Section 121020, to the test subject’s providers of health care, as defined in Section 56.05 of the Civil Code, for purposes of diagnosis, care, or treatment of the patient, except that for purposes of this section, “providers of health care” does not include a health care service plan regulated pursuant to Chapter 2.2 (commencing with Section 1340) of Division 2.(b)  Recording or disclosure of HIV test results pursuant to subdivision (a) does not authorize further disclosure unless otherwise permitted by law.(Amended by Stats. 2013, Ch. 444, Sec. 14. (SB 138) Effective January 1, 2014.)